Albano Domenico
Università degli Studi di Brescia, Brescia, Italy.
Nuclear Medicine Department, ASST Spedali Civili of Brescia, Brescia, Italy.
Br J Haematol. 2024 Dec;205(6):2134-2135. doi: 10.1111/bjh.19852. Epub 2024 Oct 27.
[F]-fluoro-D-glucose positron emission tomography/computed tomography (F-FDG PET/CT) is a non-invasive imaging tool that has a fundamental role in the management of FDG-avid lymphoma (also FL) in different settings, especially in the evaluation of treatment response and prognostication. The report by Barraclough et al. demonstrated that the treatment response evaluation by F-FDG PET/CT was a strong predictor of prognosis in grade 3B follicular lymphoma (G3BFL). Moreover, among semiquantitative baseline PET features, standardized uptake value (SUV) and TGL showed to be useful in predicting progression-free survival (PFS). Commentary on: Barraclough et al. The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphoma. Br J Haematol 2024; 205:2254-2261.
[F]-氟代-D-葡萄糖正电子发射断层扫描/计算机断层扫描（F-FDG PET/CT）是一种非侵入性成像工具，在不同情况下对FDG摄取阳性淋巴瘤（包括滤泡性淋巴瘤[FL]）的管理中发挥着重要作用，尤其是在评估治疗反应和预后方面。Barraclough等人的报告表明，F-FDG PET/CT评估的治疗反应是3B级滤泡性淋巴瘤（G3BFL）预后的有力预测指标。此外，在半定量基线PET特征中，标准化摄取值（SUV）和总糖酵解（TGL）在预测无进展生存期（PFS）方面显示出有用性。评论：Barraclough等人。3B级滤泡性淋巴瘤中半定量PET特征和治疗结束时PET的价值。《英国血液学杂志》2024年；205:2254 - 2261。
